Your browser doesn't support javascript.
loading
Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer.
Li, Bozhao; Qi, Feilong; Zhu, Fei; Lu, Zefang; Wang, Meiqi; Chu, Tianjiao; Wu, Suying; Wei, Jingyan; Song, Zhenchuan; Sukumar, Saraswati; Zhang, Cheng; Xu, Jiangfei; Li, Suping; Nie, Guangjun.
Afiliación
  • Li B; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, P.R. China.
  • Qi F; College of Pharmaceutical Science, Jilin University, Changchun, P.R. China.
  • Zhu F; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, P.R. China.
  • Lu Z; Key Lab of Organic Optoelectronics and Molecular Engineering, Department of Chemistry, Tsinghua University, Beijing, P.R. China.
  • Wang M; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, P.R. China.
  • Chu T; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, P.R. China.
  • Wu S; Breast Center, Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China.
  • Wei J; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, P.R. China.
  • Song Z; College of Pharmaceutical Science, Jilin University, Changchun, P.R. China.
  • Sukumar S; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, P.R. China.
  • Zhang C; College of Pharmaceutical Science, Jilin University, Changchun, P.R. China.
  • Xu J; Breast Center, Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China.
  • Li S; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Nie G; School of Computer Science, Key Lab of High Confidence Software Technologies, Peking University, Beijing, P.R. China.
Cancer Res ; 83(17): 2924-2937, 2023 09 01.
Article en En | MEDLINE | ID: mdl-37326467
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores de Estrógenos / Neoplasias Límite: Animals Idioma: En Revista: Cancer Res Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores de Estrógenos / Neoplasias Límite: Animals Idioma: En Revista: Cancer Res Año: 2023 Tipo del documento: Article